Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study
- PMID: 18971019
- DOI: 10.1053/j.ajkd.2008.06.034
Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study
Comment on
-
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.Am J Kidney Dis. 2008 Jun;51(6):952-65. doi: 10.1053/j.ajkd.2008.02.298. Epub 2008 Apr 18. Am J Kidney Dis. 2008. PMID: 18423809 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
